Showing results (251-260 of 274) with videos related to

Sort By:
Pageof 28
Cancer Discovery|May 15, 2016
High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical TrialAlex Pearson, Elizabeth Smyth, Irina S Babina, et al.
Oncotarget|January 26, 2023
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)Leo I Gordon, Reem Karmali, Jason B Kaplan, et al.
Annals of Surgery|March 13, 2013
Optimal management of gastric cancer: results from an international RAND/UCLA expert panelNatalie Coburn, Rajini Seevaratnam, Lawrence Paszat, et al.
Surgery|October 1, 2013
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panelMatthew Dixon, Alyson Mahar, Lawrence Paszat, et al.
The Lancet. Gastroenterology & Hepatology|September 10, 2021
Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelinesGlenn K Bonney, Claire Alexandra Chew, Peter Lodge, et al.
Annals of Surgical Oncology|September 4, 2012
A RAND/UCLA appropriateness study of the management of familial gastric cancerMatthew Dixon, Rajini Seevaratnam, Debrah Wirtzfeld, et al.
Clinical Chemistry|August 29, 2018
Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA SequencingSonia Mansukhani, Louise J Barber, Dimitrios Kleftogiannis, et al.
The New England Journal of Medicine|February 2, 2022
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell CarcinomaYuichiro Doki, Jaffer A Ajani, Ken Kato, et al.
JAMA Surgery|November 15, 2013
Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panelSavtaj S Brar, Alyson L Mahar, Lucy K Helyer, et al.
Gut|November 17, 2020
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancersElizabeth C Smyth, Georgios Vlachogiannis, Somaieh Hedayat, et al.
Pageof 28